uniQure N.V. Investing Cash Flow
uniQure N.V. (QURE) reported Investing Cash Flow of $98.56 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-05
- uniQure N.V. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $98.56M, a 390.37% increase year-over-year.
- uniQure N.V. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$441.37M.
- uniQure N.V. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $26.58M, a 44.24% decline year-over-year.
- uniQure N.V. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $73.07M, a 6.24% decline year-over-year.
- uniQure N.V. net cash provided by (used in) investing activities for fiscal 2025 was -$321.62M, a 297.35% decline from fiscal 2024.
- uniQure N.V. net cash provided by (used in) investing activities for fiscal 2024 was $162.97M.
- uniQure N.V. net cash provided by (used in) investing activities for fiscal 2023 was -$205.69M.
- uniQure N.V. net cash provided by (used in) investing activities for fiscal 2022 was -$182.73M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $98.56M 10-Q · filed 2026-05-05 | -$342.81M derived: sum of 2 quarters · filed 2026-05-05 | -$316.23M derived: sum of 3 quarters · filed 2026-05-05 | -$243.16M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | -$441.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$414.79M derived: sum of 2 quarters · filed 2026-03-02 | -$341.72M derived: sum of 3 quarters · filed 2026-03-02 | -$321.62M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $26.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $99.65M derived: sum of 2 quarters · filed 2025-11-10 | $119.75M 10-Q · filed 2025-11-10 | $93.13M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-06-30 | $73.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $93.17M 10-Q · filed 2025-07-29 | $66.55M derived: sum of 3 quarters · filed 2026-05-05 | $114.22M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-03-31 | $20.10M 10-Q · filed 2026-05-05 | -$6.53M derived: sum of 2 quarters · filed 2026-05-05 | $41.15M derived: sum of 3 quarters · filed 2026-05-05 | $119.08M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$26.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $21.05M derived: sum of 2 quarters · filed 2026-03-02 | $98.98M derived: sum of 3 quarters · filed 2026-03-02 | $162.97M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $47.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $125.61M derived: sum of 2 quarters · filed 2025-11-10 | $189.59M 10-Q · filed 2025-11-10 | $249.15M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $77.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $141.92M 10-Q · filed 2025-07-29 | $201.48M derived: sum of 3 quarters · filed 2026-03-02 | -$112.58M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $63.98M 10-Q · filed 2025-05-09 | $123.55M derived: sum of 2 quarters · filed 2026-03-02 | -$190.52M derived: sum of 3 quarters · filed 2026-03-02 | -$144.69M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $59.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$254.50M derived: sum of 2 quarters · filed 2026-03-02 | -$208.67M derived: sum of 3 quarters · filed 2026-03-02 | -$205.69M 10-K · filed 2026-03-02 | |
| 2023-09-30 | -$314.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$268.24M derived: sum of 2 quarters · filed 2024-11-05 | -$265.25M 10-Q · filed 2024-11-05 | -$433.46M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $45.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $48.82M 10-Q · filed 2024-08-01 | -$119.39M derived: sum of 3 quarters · filed 2025-02-27 | -$124.46M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $2.99M 10-Q · filed 2024-05-07 | -$165.22M derived: sum of 2 quarters · filed 2025-02-27 | -$170.29M derived: sum of 3 quarters · filed 2025-02-27 | -$174.87M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$168.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$173.28M derived: sum of 2 quarters · filed 2025-02-27 | -$177.85M derived: sum of 3 quarters · filed 2025-02-27 | -$182.73M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$9.64M derived: sum of 2 quarters · filed 2023-11-07 | -$14.52M 10-Q · filed 2023-11-07 | -$18.07M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | -$4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$9.46M 10-Q · filed 2023-08-01 | -$13.01M derived: sum of 3 quarters · filed 2024-02-28 | -$70.66M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | -$4.88M 10-Q · filed 2023-05-09 | -$8.43M derived: sum of 2 quarters · filed 2024-02-28 | -$66.08M derived: sum of 3 quarters · filed 2024-02-28 | -$68.39M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$61.20M derived: sum of 2 quarters · filed 2024-02-28 | -$63.51M derived: sum of 3 quarters · filed 2024-02-28 | -$67.39M 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$57.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$59.96M derived: sum of 2 quarters · filed 2022-11-02 | -$63.83M 10-Q · filed 2022-11-02 | -$66.53M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$6.19M 10-Q · filed 2022-08-08 | -$8.89M derived: sum of 3 quarters · filed 2023-02-27 | -$11.07M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | -$3.88M 10-Q · filed 2022-05-02 | -$6.57M derived: sum of 2 quarters · filed 2023-02-27 | -$8.75M derived: sum of 3 quarters · filed 2023-02-27 | -$10.47M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$4.88M derived: sum of 2 quarters · filed 2023-02-27 | -$6.59M derived: sum of 3 quarters · filed 2023-02-27 | -$9.48M 10-K · filed 2023-02-27 | |
| 2020-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | -$3.90M derived: sum of 2 quarters · filed 2021-10-25 | -$6.79M 10-Q · filed 2021-10-25 | -$8.75M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | -$4.61M 10-Q · filed 2021-07-26 | -$6.57M derived: sum of 3 quarters · filed 2022-02-25 | -$8.82M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | -$2.89M 10-Q · filed 2021-05-10 | -$4.85M derived: sum of 2 quarters · filed 2022-02-25 | -$7.11M derived: sum of 3 quarters · filed 2022-02-25 | -$8.31M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$4.22M derived: sum of 2 quarters · filed 2022-02-25 | -$5.42M derived: sum of 3 quarters · filed 2022-02-25 | -$6.65M 10-K · filed 2022-02-25 | |
| 2019-09-30 | -$2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$3.45M derived: sum of 2 quarters · filed 2020-10-27 | -$4.68M 10-Q · filed 2020-10-27 | -$5.43M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$2.43M 10-Q · filed 2020-07-30 | -$3.17M derived: sum of 3 quarters · filed 2021-03-01 | -$4.03M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$1.23M 10-Q · filed 2020-04-29 | -$1.97M derived: sum of 2 quarters · filed 2021-03-01 | -$2.83M derived: sum of 3 quarters · filed 2021-03-01 | -$4.83M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$1.60M derived: sum of 2 quarters · filed 2021-03-01 | -$3.60M derived: sum of 3 quarters · filed 2021-03-01 | -$4.25M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$861.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | -$2.85M derived: sum of 2 quarters · filed 2019-10-28 | -$3.50M 10-Q · filed 2019-10-28 | -$4.72M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | -$2.64M 10-Q · filed 2019-07-29 | -$3.86M derived: sum of 3 quarters · filed 2020-03-02 | -$4.82M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$648.00K 10-Q · filed 2019-04-29 | -$1.86M derived: sum of 2 quarters · filed 2020-03-02 | -$2.82M derived: sum of 3 quarters · filed 2020-03-02 | -$4.26M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$2.17M derived: sum of 2 quarters · filed 2020-03-02 | -$3.61M derived: sum of 3 quarters · filed 2020-03-02 | -$5.58M 10-K · filed 2020-03-02 | |
| 2017-09-30 | -$960.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$2.40M derived: sum of 2 quarters · filed 2018-11-06 | -$4.37M 10-Q · filed 2018-11-06 | -$4.93M 10-Q · filed 2017-11-01 | -$7.99M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$3.41M 10-Q · filed 2018-08-08 | -$7.03M derived: sum of 3 quarters · filed 2019-02-28 | ||
| 2017-03-31 | -$1.97M 10-Q · filed 2018-04-30 | -$5.59M derived: sum of 2 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$17.17M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | -$13.55M 10-Q · filed 2017-11-01 | ||||
| 2015-12-31 | -$8.02M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |